What's new

EMEA-003302-PIP01-22-M01

EMEA-003302-PIP01-22-M01

Jun 24, 2025 - 16:30
 0
EMEA-003302-PIP01-22-M01
EMEA-003302-PIP01-22-M01
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Briumvi, Ublituximab,...

Next Article

EMEA-000835-PIP01-10-M01

Related Posts

Human medicines European public assessment report (EPAR): Colobreathe, colistimethate sodium, Date of authorisation: 13/02/2012, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0

EMEA-003196-PIP01-22-M01

EMEA-003196-PIP01-22-M01

Jun 24, 2025  0

Human medicines European public assessment report (EPAR): Clopidogrel TAD, clopidogrel, Date of authorisation: 23/09/2009, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0